L-erythro MAPP (CAS 143492-38-0 (D-isomer))

L-erythro MAPP (1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) is a synthetic analog of the naturally occurring phospholipid platelet-activating factor (PAF). Unlike PAF, which is a potent mediator involved in various biological processes including inflammation and thrombosis, L-erythro MAPP is characterized by a modified acetyl group at the second position, which influences its interaction with the PAF receptor. In research, L-erythro MAPP has been utilized extensively to study the specific mechanisms of PAF receptor activation and signaling, providing insights into receptor dynamics and specificity. This chemical acts as a PAF receptor agonist but with distinct pharmacological properties, thereby allowing scientists to dissect the nuances of receptor-ligand interactions and the resulting signal transduction pathways. Through such studies, researchers are able to explore the broad implications of PAF signaling in cellular communication, immune response, and inflammation without the interference from endogenous PAF molecules. Additionally, L-erythro MAPP serves as a tool in studying the metabolic pathways involved in phospholipid synthesis and turnover, helping to clarify how cells regulate the production and degradation of critical signaling molecules like PAF. This research furthers our understanding of lipid-mediated cellular processes and can explain mechanisms pertinent to inflammation and immune regulation.